Soterix Medical
15
4
4
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
11%
1 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
TACS to Engage Theta-Gamma Coupling and Enhance Working Memory in Patients With MCI (tACS-MCI)
Role: collaborator
Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder
Role: collaborator
Ketamine Biomarker Validation
Role: lead
Parcel-guided rTMS for Major Depressive Disorder
Role: lead
Transcranial Direct Current Stimulation for Depression
Role: lead
Virtual Neuro-Navigation System for Personalized Community Based TMS
Role: lead
Development of Neuro-Navigated Transcranial Magnetic Stimulation (TMS) Using MRI
Role: lead
SMART Stimulation: Precision Neuromodulation of Cognition in Older Adults
Role: collaborator
The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study
Role: collaborator
The Effects of Compensatory Auditory Stimulation and Transcranial Direct Current Stimulation on Tinnitus Perception
Role: lead
TDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study
Role: lead
TDCS for Cocaine Addiction Craving
Role: lead
Targeted Electrotherapy for Aphasia Stroke Rehabilitation (TEASER) - Phase II Multi-Center Study
Role: lead
Home-administered tDCS for Treatment of Depression
Role: lead
Effects of tDCS Versus HD-tDCS for Stroke Rehabilitation
Role: lead
All 15 trials loaded